| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.52M | $2.16M | - | |
| CEO | 976.1K | $1.39M | - | |
| Other | 60.0K | $85.2K | - | |
| Other | 46.5K | $66.0K | - | |
| Dir | 29.8K | $42.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2022 | Smith Stan | Director | Buy | 1,971 | $3.49 | $6,883.79 | +0.2% | -2.0% | -66.7% | |
| Dec 28, 2022 | Smith Stan | Director | Buy | 1,870 | $3.40 | $6,358.58 | +0.2% | +2.0% | -63.7% | |
| Dec 23, 2022 | Smith Stan | Director | Buy | 1,712 | $3.40 | $5,825.99 | +0.2% | -8.4% | -67.2% | |
| Dec 21, 2022 | Smith Stan | Director | Buy | 4,447 | $3.52 | $15,658.01 | +0.4% | -7.6% | -68.9% | |
| Sep 19, 2022 | Smith Stan | Director | Buy | 2,700 | $3.69 | $9,958.68 | +0.2% | -8.4% | -56.2% | |
| Sep 13, 2022 | Guerrero Ramiro | Director | Buy | 8,799 | $3.85 | $33,875.11 | +3.0% | -10.1% | -53.1% | |
| Aug 30, 2022 | Guerrero Ramiro | Director | Buy | 283 | $3.97 | $1,124.74 | - | -6.7% | -54.5% | |
| Aug 1, 2022 | Gryaznov Sergei | Chief Scientific Officer | Buy | 3,000 | $5.00 | $15,000.00 | +13.9% | -53.2% | -71.9% | |
| Aug 1, 2022 | Luput Cristian | Director | Buy | 500 | $5.00 | $2,500.00 | +0.2% | -53.2% | -71.9% | |
| Aug 1, 2022 | Louie Ngar Yee52 | Director | Buy | 20,000 | $5.00 | $100,000.00 | +2.2% | -53.2% | -71.9% |